| Rotech Of Hazard | |
| 110 Corporate Dr, Ste 101, Hazard, Kentucky 41701 | |
| (606) 436-2683 |
| Name | Rotech Of Hazard |
|---|---|
| Organization Name | Lovejoy Medical Inc |
| Location | 110 Corporate Dr, Ste 101, Hazard, Kentucky 41701 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (606) 436-2683 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis Society of Canada and the MS Scientific ResearchFoundation to assess the efficacy of a mixed-method intervention to improve cognition in people with progressive MS.
Novel research shows that a blood test can differentiate elderly concussion patients with brain tissue damage from those without it. This finding, published in the special brain health collection of AACC's The Journal of Applied Laboratory Medicine, could help ensure that elderly patients with severe concussions receive crucial treatment for their injuries.
ThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today reported results for the fourth quarter and all of fiscal 2009.
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
› Verified 6 days ago
| NPI Number | 1033199641 |
| Organization Name | LOVEJOY MEDICAL INC |
| Doing Business As | ROTECH OF HAZARD |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 110 Corporate Dr, Suite 101, Hazard, KY 41701 |
| Phone Number | 606-436-2683 |
News Archive
Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis Society of Canada and the MS Scientific ResearchFoundation to assess the efficacy of a mixed-method intervention to improve cognition in people with progressive MS.
Novel research shows that a blood test can differentiate elderly concussion patients with brain tissue damage from those without it. This finding, published in the special brain health collection of AACC's The Journal of Applied Laboratory Medicine, could help ensure that elderly patients with severe concussions receive crucial treatment for their injuries.
ThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today reported results for the fourth quarter and all of fiscal 2009.
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
› Verified 6 days ago
News Archive
Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis Society of Canada and the MS Scientific ResearchFoundation to assess the efficacy of a mixed-method intervention to improve cognition in people with progressive MS.
Novel research shows that a blood test can differentiate elderly concussion patients with brain tissue damage from those without it. This finding, published in the special brain health collection of AACC's The Journal of Applied Laboratory Medicine, could help ensure that elderly patients with severe concussions receive crucial treatment for their injuries.
ThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today reported results for the fourth quarter and all of fiscal 2009.
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
› Verified 6 days ago
Arh Medical Mall Homecare Store Type: Pharmacy Location: 210 Black Gold Blvd, Hazard, Kentucky 41701 Phone: (606) 487-7333 | |
Complete Care Pharmacy Pllc Type: Pharmacy Location: 572 Morton Blvd, Hazard, Kentucky 41701 Phone: (606) 487-1910 | |
Cooley Medical Equipment Type: DME Supplier - Oxygen Equipment & Supplies Location: 500 Village Ln, Hazard, Kentucky 41701 Phone: (606) 439-4049 | |
Cvs Pharmacy #06343 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 30 S Ky Highway 15, Hazard, Kentucky 41701 Phone: (606) 436-3128 | |
Cvs Pharmacy #10155 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 102 Village Lane, Hazard, Kentucky 41701 Phone: (606) 435-2363 |